PECA Labs

PECA Labs is a privately held, Pittsburgh-based medical device innovator founded in 2011 by Carnegie Mellon alumni. The company leverages a proprietary polymeric material platform to develop advanced vascular grafts and heart valves designed to address limitations of current devices, particularly in pediatric populations. Its pipeline includes several products in development, with its MASA Valve pulmonary conduit currently in a U.S. clinical trial. PECA Labs is led by a young, award-winning founding team and an experienced board with deep industry expertise.

Proprietary polymeric material platform designed to be highly bio-inert, enabling features like radiopacity for visualization, controllable expandability for growth, and slim delivery profiles without relying on pharmaceutical coatings.

PECA Labs competes against giant, well-funded medtech companies like Medtronic, Edwards Lifesciences, and Abbott in the heart valve and vascular graft markets. Its differentiation lies in its polymer platform and focus on pediatric/growth-accommodating designs, which are underserved segments by the major players who focus on larger adult markets.